Case Study

Opioid Reformulation For Abuse Deterrence

Regulatory and compliance

Read this case study to learn how Recro Gainesville helped a client achieve a complex reformulation and subsequent successful CMC supplement filing in less than a year.

A CMC prior approval supplement (PAS) for a reformulated pharmaceutical under the FDA scale-up and post-approval changes (SUPAC) guidance can enable developers to:

  • Save time
  • Avoid millions of dollars in clinical study conduct costs
  • Achieve FDA approval

Recro can help pave the way for your successful CMC PAS filing by simplifying and isolating proposed changes and using a risk-based scientific approach to minimize clinical impact. Then, as your partner, our scientific team will apply decades of experience and expertise to enable the rapid development of your new formulation — and help you present a confident, science-based case to your regulatory agency. Download our case study to learn more.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: